Surgepays Inc (SURG) Stock Analysis
Verdict: AVOID
Severe liquidity crisis and negative margins following ACP funding loss make this a high-probability bankruptcy candidate.
Investment score: 12/100
Analysis as of
Is Surgepays Inc stock worth reviewing? AI model thesis
SurgePays is currently in a state of financial distress with deteriorating fundamentals and zero margin of safety.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 10/100 (weight 15%)
- Earnings Quality: 5/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 40/100 (weight 10%)
- Risk-Adjusted Return: 5/100 (weight 15%)
Surgepays Inc opportunities and risks
What speaks for SURG
- Potential Re-funding of ACP or Alternative Subsidies
What speaks against SURG
- Insolvency/Bankruptcy Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| SURG | n/a | 0.1x | n/a | -19.6% | -47.9% | -279.1% |
| SPOK | 17.6x | 1.6x | 9.0x | 88.1% | 9.0% | 11.6% |
| OMCC | n/a | 2.4x | 94.4x | 68.0% | -25.1% | -51.5% |
| KTEL | n/a | 0.9x | n/a | 34.3% | -13.0% | -27.8% |
| AKOM | n/a | 0.0x | n/a | 0.0% | 0.0% | -602.5% |
| Peer median | n/a | 1.3x | 3.8x | 51.1% | -6.5% | -39.7% |
Frequently asked questions about Surgepays Inc (SURG)
Is SURG stock a good investment?
The cached TradeMates AI model rates Surgepays Inc as AVOID with an investment score of 12/100. SurgePays is currently in a state of financial distress with deteriorating fundamentals and zero margin of safety. This is algorithmic model output, not personal investment advice.
Is SURG stock a buy?
The TradeMates model verdict for SURG is AVOID with an investment score of 12/100. Treat this as a model signal to review, not a personal buy recommendation.